Medicine and Dentistry
Adjuvant Therapy
13%
Adverse Event
16%
Alteplase
33%
Biliary Tract Drainage
33%
Blood Clot Lysis
37%
Cholangiocarcinoma
33%
Colorectal Liver Metastasis
100%
Critical Limb Ischemia
33%
Disease
21%
Disease Burden
11%
Embolization
33%
Endoleak
33%
Fenestrated Endovascular Aneurysm Repair
33%
Fenestration
30%
Fibrinolytic Therapy
9%
Group Trial
33%
Hazard Ratio
16%
Hemihepatectomy
8%
Hepatectomy
49%
Hepatic Portal Vein
66%
Intention-to-Treat Analysis
11%
Interim Analysis
11%
Limb Salvage
27%
Liver Surgery
8%
Liver Transplantation
33%
Local Therapy
24%
Meta-Analysis
33%
Metastatic Carcinoma
38%
Microwave Thermotherapy
33%
Neoplasm
28%
Noninferiority Trial
33%
Odds Ratio
16%
Overall Survival
26%
Pediatrics
33%
Percutaneous Transluminal Angioplasty
27%
Portal Vein Thrombosis
33%
Progression Free Survival
12%
Radiation Therapy
33%
Randomized Controlled Trial
72%
Renal Artery
20%
Revascularization
41%
Stenosis
33%
Stereotactic Body Radiation Therapy
31%
Streptokinase
11%
Surgery
33%
Systematic Review
33%
Thrombectomy
50%
Treatment Group
16%
Tumor Progression
8%
Umbilical Vein
33%
Keyphrases
Acute Limb Ischemia
33%
AngioJet
5%
Catheter
22%
Cochrane Library
5%
Colorectal Liver Metastases
33%
Confidence Interval
16%
Embase
5%
Endovascular
11%
Endovascular Revascularization
33%
Extended Hemihepatectomy
8%
Fibrinolytic Agents
5%
Hemorrhagic Complications
11%
Hepatoduodenal Ligament
8%
High Dose
5%
High Risk
5%
Hybrid Method
5%
Initial Treatment
5%
Irreversible Electroporation
6%
Left Portal Vein
8%
Limb Salvage
16%
Limb Salvage Rate
11%
Local Control
8%
Local Tumor Progression
8%
Low Quality Data
5%
Major Vascular Injury
11%
Meta-analysis
33%
Microwave Ablation
33%
Multicenter Randomized Controlled Trial
33%
No Significant Difference
5%
Odds Ratio
16%
Outcome Reporting
5%
Perihilar
6%
Portal Shunt
19%
Progression-free Survival
12%
Randomized Controlled Trial
18%
Recombinant Tissue Plasminogen Activator (rt-PA)
33%
Revascularization
33%
Standardized Practices
5%
Stereotactic Ablative Radiotherapy
33%
Stereotactic Body Radiotherapy
25%
Streptokinase
11%
Surgical Revascularization
33%
Systematic Meta-analysis
33%
Thrombectomy
16%
Thrombolysis
33%
Thrombolytic Therapy
5%
Tumor
8%
Tumor Resectability
6%
Ultrasound
5%
Urokinase
5%
